161 related articles for article (PubMed ID: 22154011)
1. Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2012 Apr; 92():98-105. PubMed ID: 22154011
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
Yordanov G; Evangelatov A; Skrobanska R
Colloids Surf B Biointerfaces; 2013 Jul; 107():115-23. PubMed ID: 23466549
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
5. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2013 Jan; 101():215-22. PubMed ID: 23010022
[TBL] [Abstract][Full Text] [Related]
6. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle.
Jung J; Lee IH; Lee E; Park J; Jon S
Biomacromolecules; 2007 Nov; 8(11):3401-7. PubMed ID: 17939711
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
9. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
Memisoglu-Bilensoy E; Vural I; Bochot A; Renoir JM; Duchene D; Hincal AA
J Control Release; 2005 Jun; 104(3):489-96. PubMed ID: 15911048
[TBL] [Abstract][Full Text] [Related]
11. In situ formation of chitosan-cyclodextrin nanospheres for drug delivery.
Wang J; Zong JY; Zhao D; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2011 Oct; 87(1):198-202. PubMed ID: 21652181
[TBL] [Abstract][Full Text] [Related]
12. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
14. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
[TBL] [Abstract][Full Text] [Related]
15. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres.
Arias JL; Gallardo V; Ruiz MA; Delgado AV
Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292
[TBL] [Abstract][Full Text] [Related]
16. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
[TBL] [Abstract][Full Text] [Related]
17. Preparation of thermoresponsive and pH-sensitivity polymer magnetic hydrogel nanospheres as anticancer drug carriers.
Fan T; Li M; Wu X; Li M; Wu Y
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):593-600. PubMed ID: 21871786
[TBL] [Abstract][Full Text] [Related]
18. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
19. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
20. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
